Dr Glauser, the study found no peri-implantitis around two-piece Patent implants after 12 years. What do you make of these results?
These results are quite spectacular! With 35 years of experience in implant dentistry as both a clinician and researcher, I am deeply engaged with scientific data. Results like these after such a long observation period are extremely rare.

Do you have an explanation of how these results were achieved?
I too asked myself this question. After analysing the implant system in detail, however, I found that the results can be explained logically. What sets Patent apart from other dental implants is its surface topography in the transmucosal region, which is “mucophilic”—attracting mucosal cells and facilitating a remarkably strong and intimate adhesion of soft tissue. This resulting “biological firewall” serves as a defence line against bacteria so to speak. Furthermore, the implant system does not have a micro-gap at the critical crestal bone level, where bacteria could accumulate. These combined factors elucidate the long-term outcomes observed in this study.

Why are the study results remarkable?
When patients lose a tooth, they experience a loss in bone volume in the medium term. If the lost tooth is replaced with an implant, bone loss or remodelling is usually to be expected. This was not the case in the present study, where bone levels remained largely stable. The soft tissue too was mainly healthy. This is particularly remarkable considering that the study included patients with a thin gingival biotype, heavy smokers and patients with compromised health as a consequence of various conditions that affect general health, such as cancer and Down’s syndrome, as well as with oral health issues, such as periodontitis.

What implications do the results have for daily implant practice?
They signify positive news for clinicians, as this advanced technology enables us to achieve superior long-term outcomes in everyday implant practice. With this implant system, we can now mitigate the risk of peri-implantitis over the long term. One could argue that, as a treating dentist, I am deciding for or against peri-implantitis by my choice of implant system.

What conclusions do you draw from this study?
With Patent, I now have a system in daily use that has been proved to prevent biological complications. This is particularly important, as studies indicate that the probability of peri-implantitis is directly correlated with various systemic diseases, such as diabetes. Looking to the future, I now have the means to mitigate this risk factor and enhance the safety of my treatment as a practitioner.

Reflecting on the study results, it is evident that the Patent Dental Implant System is not indicated only for special cases; it is the go-to implant system for everyday use. With this advanced technology, the time for change is now!

Topics:

Tags: